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PURPOSE. The purpose of this study was to investigate the expression of death ligands in
the lacrimal glands (LGs), identify upstream factors that regulate their expression, and
determine the functional roles of these factors in the pathogenesis of dry eye disease
(DED).
METHODS. For DED experiment, ex vivo coculture system with LG and in vivo murine
model using a controlled environment chamber were utilized. C57BL/6 mice and hypoxia-
inducible factor (HIF)-1α conditional knockout (CKO) mice were used. Immunohis-
tochemical staining, polymerase chain reaction, and immunoblotting were performed
to determine levels of death ligands including tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL) in DED-induced LGs. Additionally, acinar cell and CD45+ cell
apoptosis was determined with neutralizing TRAIL treatment.
RESULTS. Desiccating stress significantly increased HIF-1α expression in LG-acinar cells.
Furthermore, HIF-1α deficiency significantly enhanced the infiltration of CD45+ inflam-
matory cells in LG and induced LG-acinar cell death. Meanwhile, only TRAIL expression
was increased in DED-LG, but abrogated in HIF-1α CKO. Interestingly, the main source
of TRAIL was the CD45– LG-acinar cells, but not CD45+ immune cells after DED induc-
tion. Using ex vivo coculture system, we confirmed LG-induced apoptosis of immune
cells via HIF-1α-mediated TRAIL secretion following DED. Consistent with ex vivo, the
insufficiency of HIF-1α and TRAIL enhanced recruitment of inflammatory cells to the LG
and subsequently exacerbated ocular surface damage in DED mice.
CONCLUSIONS. Our findings offer novel insight into the regulatory function of acinar cell-
derived TRAIL in limiting inflammatory damage and could be implicated in the develop-
ment of potential therapeutic strategies for DED.
Keywords: death ligand, tumor necrosis factor-related apoptosis-inducing ligand,
hypoxia-inducible factor-1α, lacrimal gland, dry eye disease
Dry eye disease (DED) is characterized by dysfunc-tion of the lacrimal functional unit, composed of the
lacrimal gland (LG), ocular surface, and connecting sensory
nerves.1 Impaired function of the LG leads to reduced tear
formation and propagates damage to the ocular surface.
Moreover, etiological factors, including desiccating stress,
induce ocular surface damage by initiating an inflammatory
cascade.2 Despite multiple reports demonstrating the major
contribution of excessive inflammation in the pathogenesis
of Sjögren and non-Sjögren DED, the mechanism by which
LG regulates the infiltration of inflammatory cells during
desiccating stress has not been fully understood.
Our previous report has shown that hypoxia-inducible
factor (HIF)-1α, an oxygen-dependent transcriptional
factor,3,4 prevents LG acinar cell damage in DED. Moreover,
LG-specific deletion of HIF-1α positively correlated with
increased infiltration of inflammatory cells during DED.
Although our previous reports elucidate the association of
HIF-1α with LG inflammation, the underlying mechanism
and immunoregulatory functions of HIF-1α in LG during
DED remains unknown.
HIF-1α has been associated with elevated expression of
death ligands,5 which have recently been shown to regu-
late inflammation by inducing cell death in cancer6,7 and
autoimmune disorders.8 As a type II integral membrane
protein of the tumor necrosis factor (TNF) family, TNF-
related apoptosis-inducing ligand (TRAIL) has been reported
to induce apoptosis of tumor cells.9 Interaction of TRAIL
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with its receptor, particularly death receptor 5 (DR5),
promotes apoptosis by activating the caspase-dependent
pathways.10,11 DcR1, a decoy receptor, lacks a signal-
ing domain and inhibits the TRAIL-induced apoptosis by
competing with DR5.9,10,12 Although the elevated tissue
levels of TRAIL have been observed in a variety of inflamma-
tory conditions,13,14 the contribution of TRAIL in regulating
desiccation-induced ocular inflammation has not been inves-
tigated.
The current study investigates the expression levels and
immunoregulatory function of death ligands in a mouse
model of DED. Our data demonstrate that acinar cell–
expressed HIF-1α upregulates the secretion of TRAIL, which
in turn limits inflammation of LG and progression of ocular
surface epitheliopathy by inducing apoptosis of infiltrating
leukocytes in DED.
MATERIALS AND METHODS
Animals, DED Induction, and Generation of
HIF-1α Conditional Knockout Model
Six- to 8-week-old male C57BL/6 mice (Charles River Labo-
ratory, Wilmington, MA) were used in accordance with
the standards set forth in the Association for Research in
Vision and Ophthalmology Statement for the Use of Animals
in Ophthalmic and Vision Research. The research proto-
col was approved by the Institutional Animal Care and
Use Committee of Yonsei University College of Medicine
(YU-2015-0190).
DED was induced by placing the mice in a controlled
environment chamber (CEC). To achieve maximum ocular
surface dryness, mice in the CEC (with relative humidity
below 13%) were given subcutaneous injections of 0.1 ml
scopolamine hydrobromide (5 mg/ml; Sigma-Aldrich Chem-
ical Co., St. Louis, MO) three times a day.
The detailed methods for generating and breeding HIF-
1α conditional knockout (CKO) mice have been described
previously.15 Concisely, mice with MMTV-Cre-dependent
knockout at the hif1α locus were generated by crossing
animals containing loxP sites flanking exon 2 of hif1α
(B6.129-Hif1αtm3Rsjo/J; Jackson Laboratory, Bar Harbor, ME).
Genotyping was performed using DNA from tail biopsies.
All experiments were performed on littermates derived from
Hif1αf/f-MMTV-Cre+ × Hif1αf/f-MMTV-Cre− (6-10 weeks
old).
Tissue Preparation
After DED induction, mice were sacrificed and LGs were
harvested on day 7 and day 10. Each tissue sample was
either fixed in 3.7% paraformaldehyde for immunostaining
or stored at -70°C for real-time quantitative polymerase chain
reaction (qPCR) or immunoblotting.
RNA Isolation and Real-Time qPCR
RNA was isolated from the mouse LGs using a RNeasy Micro
Kit (QIAGEN, Valencia, CA), and reverse transcription was
performed using a Superscript III Kit (Invitrogen, Carlsbad,
CA). Real-time qPCR was performed using SYBR Premix Ex
Taq (Takara Bio Inc., Otsu, Japan) with a StepOnePlus real-
time qPCR System (Applied Biosystems, Foster City, CA).
Preformulated primers for TRAIL (Mm01283606_m1), HIF-
1α (Mm00468869_m1), and glyceraldehyde-3-phosphate
dehydrogenase (Mm_001289726_m1) were sourced from
Applied Biosystems (Carlsbad, CA) to evaluate messenger
RNA (mRNA) expression. The mRNA primer sequences for
DcR1, programmed death ligand-1 (PDL-1), and FasL were
custom designed as described in Supplementary Table S1.
Gapdh served as an internal control, and gene expression
was presented as fold change from the control. The anal-
ysis was performed using the comparative threshold cycle
method.
Immunohistochemical Staining
The immunohistochemical (IHC) staining method for LGs
has been described previously.15 Briefly, LGs were harvested,
and histologic sections (5-7 μm) were collected on poly-
L-lysine-coated slides and deparaffinized. Sections were
blocked with rabbit, goat, or rat serum for 40 min at room
temperature and exposed to primary antibodies: TRAIL
(Abcam Inc., UK), CD11b (Abcam Inc.) and HIF-1α (Abcam
Inc.). Antibodies were diluted 1:100 to 1:200 and incu-
bated overnight at 4°C. After washing in Tris-buffered saline
supplemented with Tween 20, each section was exposed to
secondary antibodies for 1 hour. After washing with Tris-
buffered saline supplemented with Tween 20, the sections
were exposed to 4’,6-diamidino-2-phenylindole (PureBlu,
Bio-Rad, Inc., Hercules, CA). Light microscopy (Axio
Imager 2, Carl Zeiss, Germany) was used to examine the
samples.
Immunoblotting
Total protein concentrations of supernatant fractions were
determined using the bicinchoninic acid (BCA) protein assay
(Bio-Rad, Inc.). Equal amounts of protein aliquots were
boiled in equal volumes of 2 × SDS Laemmli sample buffer
and resolved by 8% or 10% (wt/vol) with primary antibod-
ies: anti-TRAIL (0.2 μg/mL; R&D System Inc., Minneapolis,
MN), anti-PDL-1 (0.1 μg/ml; Cell Signaling Inc.), anti-DR5
(1 μg/mL; R&D System Inc.), anti-mDcR1 (1 μg/mL; R&D
System Inc.), and anti-β-actin (2 μg/ml; Abcam Inc., UK).
β-actin was used as an internal loading control.
Terminal Deoxynucleotidyl TUNEL Staining
LGs were fixed in 10% buffered formalin. Sections (7 μm)
were cut, fixed, deparaffinized, and processed using a
commercial kit (Oncogene Research Products, Boston, MA)
according to the manufacturer’s protocol. Sections were
analyzed using the Eclipse E600 microscope (Nikon, Tokyo,
Japan). Apoptotic cells (dark spots) were counted in 10
random high-power fields.
LG Organ Culture Ex Vivo
LG organ culture was performed as previously described.16
Briefly, LGs were isolated and washed three times with ster-
ile RPMI solution. Afterward, they were placed on the upper
chamber of a Transwell system (1.2 μm-pore sized, Corn-
ing, Inc., Canton, NY) and immersed in an organ culture
medium with or without 1.0 or 10 μM anti-TRAIL neutral-
izing antibody (Abcam Inc.; ND50, 0.2-2.0 μM), control IgG
(1.0 μM, Biolegend, Inc., San Diego, CA), control glutathione-
S-transferase (GST; 50 ng/mL), soluble recombinant TRAIL
(20 ng/mL and 50 ng/mL). Approximately 1.75 × 105 periph-
eral blood mononuclear cells (PBMCs) were placed in the
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lower chamber. To make single-cell suspensions of PBMCs,
whole blood cells were separated by Histopaque 1083
(Sigma-Aldrich) density gradient and centrifuged as previ-
ously described.17,18 At 2, 6, and 24 hours, culture super-
natants were harvested for ELISA analysis and leukocytes
were used for flow analysis to determine apoptosis and
proliferation as described in the following section.
ELISA
The concentration of IL-1β and TNF-α (R&D Inc.) and IL-
17A (BioLegend Inc.) in lysates of LGs were assessed using
ELISA according to the manufacturer’s protocols. Levels of
TRAIL in culture supernatants were evaluated using ELISA
(Abcam, Inc.). All the experiments were repeated three times
with at least triplicated samples.
Flow Cytometry
Single-cell suspensions of four LGs from each condition were
prepared by treating minced tissue fragments with 100 U/mL
collagenase D and 15 μg/mL DNase (Sigma-Aldrich) for
40 minutes at 37°C. After blocking with 1 μg of unla-
beled anti-FcrR antibody (clone 2.4G2), cells (1 × 106)
were washed with RPMI 1640 and surface-stained with
fluorochrome-conjugated anti-CD11b, anti-CD45, anti-
TRAIL, anti-Annexin V (eBioscience, San Diego, CA), or
the appropriate isotype controls and then analyzed with
FACS (FACSCalibur, Becton-Dickinson, Mountain View,
CA). For purification of CD45− acinar cells and CD45+
leukocytes, single-cell suspensions of LGs were stained with
fluorochrome-conjugated anti-CD45 and sorted using FACS
ARIA (Becton-Dickinson).
Fluorescein Staining
Corneal erosion grading used in this study was performed
as previously described.19,20 Briefly, before observation,
the mice were anesthetized by Zoletil (tiletamine HCl and
zolazepam HCl, Virbac). Then, corneal epitheliopathy was
evaluated by placing 2 μL of 2.5% sodium fluorescein (vital
staining) on the ocular surface for 3 minutes and examined
under cobalt blue light using a slit-lamp biomicroscope. To
avoid interobserver variation, the fluorescein-stained area
(an indicator of corneal defects) were observed by two inde-
pendent observers (Y.W.J. and E.Y.C.) and the calculated
mean value from the erosion scores were used. Punctate
staining was evaluated using the Oxford Scheme grading
system and a grade of 0 to 4 were assigned.
Statistical Analysis
Continuous variables were examined for normal distribu-
tion by the Kolmogorov-Smirnov test. Variables that deviated
from normal distribution were presented in mean and stan-
dard deviation, and those that were not normally distributed
were presented as the median and interquartile range. For
two-sample analysis, Mann-Whitney U test or Student’s t-test
were used. Kruskal-Wallis or one-way ANOVA was used to
make comparisons among three or more groups. Bonferroni-
corrected Dunnett’s procedure was used as a post hoc
analysis to compare each treated group to the control
group. Statistical analysis was performed using SAS (version
9.13; SAS, Cary, NC) and R (version 3.2.5; Statistics and
Mathematics, Vienna, Austria). Results are presented as the
mean ± standard deviation. P value < 0.05 was considered
significant.
RESULTS
HIF-1α Regulates LG Inflammation and Inhibits
Acinar Cells Apoptosis
HIF-1α is a transcriptional regulator that promotes cell
survival during hypoxia-related pathological conditions.21,22
To investigate whether HIF-1α regulates LG inflammation
following desiccating stress, we utilized a widely used
murine model of DED.15,23,24 As a result, the qPCR exper-
iment demonstrated a significant 3- to 4-fold increase in
expression of HIF-1α transcript in the LGs of DED mice,
compared with naive controls (Fig. 1A). Consistent with the
mRNA analysis, our immunoblot data further confirmed the
higher expression of HIF-1α at protein levels in DED-LGs
(Fig. 1B). Next, IHC staining was performed to determine
the cellular expression of HIF-1α in the LG. HIF-1α expres-
sion was observed primarily in acinar cells (indicated by
the yellow arrowheads), with undetectable levels in ductal
cells and infiltrating leukocytes (Fig. 1C). Using genetically
modified mice in which HIF-1α was conditionally deleted in
LGs (HIF-1α CKO mice),15 we assessed whether HIF-1α defi-
ciency augments inflammatory responses in LG during DED.
Single-cell suspension of harvested LGs was prepared on day
7 and day 10, and flow cytometry analysis was performed.
HIF-1α deficiency significantly increased the infiltration of
CD45+ inflammatory cells in the LG following DED induc-
tion, compared with the wild-type (WT) controls (Fig. 1D).
Furthermore, following DED induction, increased frequen-
cies of annexin V+ CD45− acinar cells were observed in the
LGs of HIF-1α CKO mice compared with the WT controls,
suggesting that HIF-1α promotes the survival of acinar cells
(Fig. 1D). Additionally, DED inductions resulted in signifi-
cantly higher levels of inflammatory cytokines, IL-1β, IL-17A,
and TNF-α in the LGs of HIF-1α CKO mice, relative to the
WT control (Figs. 1E-G).
TRAIL Expression Increases in LG During DED
HIF-1α has been shown to induce the expression of death
ligand PDL-1 in tumor cells.25 Given the increased levels HIF-
1α following DED induction, LG of DED mice were screened
for the expression of potential death ligands that have been
shown to regulate the immune response in various disor-
ders.26–28 The expression of TRAIL, PDL-1, and FAS-L was
evaluated in the LGs on day 7 following DED induction
(Fig. 2A). Desiccating stress significantly increased (3-fold)
mRNA expression of TRAIL and did not alter the expres-
sion of PDL-1. Additionally, low levels of FAS-L were
observed in DED-LG. Consistent with the mRNA analysis,
our immunoblot data demonstrated increased protein level
of TRAIL after DED induction (Fig. 2B). Unlike the LG, the
cornea, brain, and skin did not express high levels of TRAIL
in DED mice (Fig. 2C).
Previous studies have reported TRAIL expression in both
immune and nonimmune cells, including keratinocytes,29,30
fibroblasts,31 and glandular cells.32 We identified the cellu-
lar source of TRAIL in the DED-LGs using flow cytome-
try and IHC staining. Flow cytometry analysis demonstrated
that the expression of TRAIL was significantly increased in
the CD45− acinar cells yet was absent in CD45+ immune
cells after DED induction (Fig. 2D). Expression of TRAIL
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FIGURE 1. HIF-1α suppresses apoptosis of acinar cells and regulates lacrimal gland inflammation. (A) Real-time qPCR and (B) immunoblot
analysis of HIF-1α in DED induced LGs (n = 5/group; **P < 0.01; one-way ANOVA, Kruskal-Wallis post hoc analysis). (C) Representative
image of immunohistochemical staining of HIF-1α in LG on indicated days following DED induction. Green arrowheads indicate staining
of HIF-1α in acinar cells (scale bar = 200 μm). (D) Representative flow cytometric plots showing increased infiltration of CD45+ immune
cells and apoptosis of CD45− acinar cells in LGs harvested from WT and HIF-1α CKO mouse on indicated days after DED induction (n =
6/group). ELISA analysis of (E) IL-1β, (F) IL-17A, and (G) TNF-α concentrations in lysates of LGs of WT and HIF-1α CKO mouse harvested
on 7 day post-DED induction (n = 6/group; *P < 0.05, **P < 0.01, ***P < 0.001; one-way ANOVA, Kruskal-Wallis post hoc analysis). The
data were from three independent experiments.
was further visualized in the acinar cell using IHC staining
(Fig. 2E).
The function of TRAIL is largely determined by the recep-
tor dominantly expressed on the target cells.33 To inves-
tigate the immunoregulatory effect of TRAIL in DED, we
evaluated the expression of DR5 (TRAIL receptor) and
mDcR1 (decoy receptor) on FACS-sorted immune cells,
and acinar cells of the LGs harvested from DED mice.
As demonstrated by immunoblot analysis, CD45+ inflam-
matory cells exhibited higher levels of DR5 and lower
levels of mDcR1, compared to CD45– acinar cells (Fig. 2F).
Our results collectively indicate that the TRAIL-DR5 axis
regulates the infiltration of CD45+ immune cells during
DED.
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FIGURE 2. TRAIL expression increases in lacrimal gland during dry eye disease. (A) Real-time qPCR analysis of TRAIL, PDL-1, and FAS-L
mRNA levels in LGs harvested on day 7 post-DED induction (n = 6/group; *P < 0.05, **P < 0.01, NS: not significant; one-way ANOVA,
Kruskal-Wallis posthoc analysis). (B) Representative immunoblot images showing protein expression of TRAIL, PDL-1 in LGs harvested
on day 7 post-DED induction. All experiments were repeated at least three times in triplicate. (C) Representative immunoblot image and
cumulative bar chart of TRAIL expression on day 7 of DED induction in the cornea (Co), LG, brain (Br), and skin (Sk) (n = 6/group; ***P <
0.001; one-way ANOVA, Kruskal-Wallis post hoc analysis). (D) Representative flow cytometric plots showing CD45−TRAIL+ acinar cells and
CD45+ TRAIL– leukocytes in LG on indicated days following DED induction (n = 6/group). (E) Immunohistochemical staining of LG showing
TRAIL expression on indicated days post-DED induction. Red arrowheads indicate TRAIL positive acinar cells. Representative images were
selected from three independent experiments (scale bar = 50 μm). (F) Flow cytometry dot plot and histogram showing gating strategy for
sorting CD45− acinar cells and CD45+ leukocytes from single-cell suspension of LGs (left). Representative immunoblot showing DR5 and
mDcR1expression on sorted CD45− acinar cells and CD45+ leukocytes on indicated days post-DED induction (n = 6/group). The data were
from three independent experiments.
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HIF-1α Promotes Apoptosis of Immune Cells by
Inducing TRAIL Expression in the LG During
DED
Our observation of increased expression of both HIF-1α and
TRAIL in DED mice led us to investigate whether HIF-1α
regulates TRAIL expression in the LG during DED. Desic-
cating stress was induced in WT, and HIF-1α CKO and LGs
were harvested on day 7. DED induction resulted in approx-
imately 2.5-fold increase in TRAIL expression at the mRNA
and protein level, yet this effect was abrogated in HIF-
1α-deficient mice (Figs. 3A, 3B). Our findings suggest that
DED-induced TRAIL expression is dependent on acinar cell-
derived HIF-1α.
Using our ex vivo LG-immune cell coculture system,
we investigated whether LG induces apoptosis of immune
cells via HIF-1α-mediated TRAIL secretion following DED
(Fig. 3C).16 Consistent with our in vivo observation, the
ELISA analysis demonstrated a significant increase in secre-
tion of TRAIL in culture supernatants of DED-LGs, compared
with naive control cultures; yet, this increase was not
observed in the supernatants of DED induced HIF-1α-CKO-
LG (Figs. 3D, 3E). Moreover, DED-induced LG significantly
amplified the frequencies of annexin-V+ apoptotic leukocyte
at 2, 6, and 24 hours after coculture, relative to naive control
(Fig. 3F). The coculture was treated with TRAIL-neutralizing
antibodies to confirm whether TRAIL promotes apoptosis of
immune cells. Neutralization of soluble TRAIL reduced the
frequency of apoptotic immune cells in a dose-dependent
manner in DED-LG cultures, compared to the IgG-treated
control (Fig. 3G). Using a gain of function approach, we
determined whether HIF-1α promotes apoptosis of inflam-
matory cell in a TRAIL-dependent manner. Cocultures of the
LGs of HIF-1α CKO and immune cells were performed in
the presence and absence of recombinant TRAIL. Our data
further demonstrated that DED-LGs of HIF-1α CKO mice
did not induce the apoptosis of immune cells and addi-
tion of recombinant TRAIL resulted in increased frequen-
cies of annexin V+ immune cells, compared with GST-treated
control (Fig. 3H). Our data collectively demonstrate that HIF-
1α promotes apoptosis of immune cells by inducing TRAIL
expression in LGs in DED.
HIF1α and TRAIL Insufficiency Results in
Enhanced LG Inflammation and Epitheliopathy in
DED
Given that knockdown of HIF-1α abrogates the expression
of TRAIL following DED induction (Fig. 3A), we used HIF-1α
CKO mice to investigate whether insufficiency of both HIF-
1α and TRAIL lead to enhanced recruitment of inflamma-
tory cells to the DED-LG and subsequently exacerbate ocular
surface damage. Infiltrating immune cells were quantified
using flow cytometry analysis. HIF-1α CKO DE-LG exhibited
a significant increase in infiltration of CD45+ total leukocyte
(3.7-fold) and CD11b+ cells (5.7-fold), compared with WT
controls (Fig. 4A). IHC data visualized the increased frequen-
cies of CD11b+ immune cells in the LG of HIF-1α CKO on
day 7 of DED induction (Fig. 4B). Furthermore, TUNEL anal-
ysis showed increased apoptosis of acinar cells (blue dots)
in interlobular space of the LG from HIF-1α CKO mice after
DED induction, relative to WT control (Fig. 4C).
Finally, to confirm the effect of HIF-1α and TRAIL on the
pathogenesis of DED, fluorescein staining of ocular surface
was performed in both WT and HIF-1α KO mice following
DED induction (Fig. 4D). HIF-1α CKO mice displayed higher
corneal erosion scores compared to the WT control, as indi-
cated by a larger fluorescein stained area in the cornea.
DISCUSSION
The present study provides novel insight into the role of
HIF-1α-mediated TRAIL expression in regulating LG inflam-
mation in DED. Specifically, our data show that (1) HIF-
1α is critical for TRAIL expression, (2) acinar cells express
elevated levels of TRAIL following desiccating stress, (3)
TRAIL and its receptor system selectively promote the
apoptosis of infiltrating leukocytes, and (4) HIF-1α and
TRAIL insufficiency result in enhanced LG inflammation and
advanced epitheliopathy in DED. Taken together, the signal
cascade from HIF-1α mediated TRAIL expression may be
a critical pathway of the innate protective mechanisms of
LGs from desiccating stress-induced inflammatory cell infil-
tration.
Though it is an old concept, the “lacrimal functional unit”
is still an actively working hypothesis describing DED as a
disturbance of the integrated system comprising of the LGs,
corneoconjunctiva, and neural networks connecting them all
to each other.1 Thus, if any component of this unit is compro-
mised, DED may occur. Within this functional unit, because
it is the main pathologic location and easily accessible, the
majority of clinicians and researchers have been focused
on the corneoconjunctival area to investigate inflammatory
markers: measuring the treatment effectiveness of various
drugs and determining the immunoinflammatory mecha-
nisms.15,19 In contrast to the ocular surface, however, it is
true that the LG has been investigated mostly as an “organ”
for tear production and less in terms of its immunoinflam-
matory mechanisms.
It is well known that extensive activation and infiltra-
tion of pathogenic immune cells including monocytes and
macrophages, result in the impaired protective function of
the LGs, leading to acute DED.2,23 In our study, inflamma-
tory cell infiltration and elevated TRAIL expression were
observed beginning from 48 hours after DED induction
(data not shown). And the TRAIL expression in acinar cells
appeared to regulate inflammatory damage by inducing
apoptosis of the infiltrating leukocytes during DED. Similar
to the ocular surface, our data strongly support the idea that
immunoinflammatory mechanisms in the LGs are important
and are activated in the LGs from an early phase of DED.
In accordance with these data, it is true that the number of
immunoinflammatory molecule expressions are three times
higher in the LGs compared with the ocular surface.34
HIF-1α has been reported to promote cell survival of
immune and nonimmune cells during hypoxia.35 Our previ-
ous report has shown that HIF-1α mediated autophagy
signals promote acinar cell survival during desiccating
stress.15 An in vitro study in which HIF-1α was knocked
down in myeloid cell has demonstrated a direct involvement
of HIF-1α in regulating neutrophil survival in hypoxia.36 We
observed that HIF-1α prevents apoptosis of acinar cell in
DED, corroborating our previous report.35
As a further study from our previous report showing
elevated HIF-1α expression in DED-induced acinar cells,
we hereby report elevated secretion of TRAIL in the LGs
during DED through the activation of HIF-1α. TRAIL has
been shown to induce apoptosis of various tumor cells
and has been implicated as a potential therapeutic target
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FIGURE 3. HIF-1α promotes apoptosis of immune cells by inducing TRAIL expression in the lacrimal gland during DED. (A) Real-time
PCR analysis of TRAIL mRNA levels in WT and HIF-1α conditional knockout (CKO) mice at baseline and day 7 of DED induction (n =
6/group; **P < 0.01). (B) Representative immunoblot image of TRAIL protein expression in WT and HIF-1α CKO mice at baseline and day
7 of DED induction. (C) Schematic diagram of ex vivo coculture of LG and PBMC. (D) ELISA analysis evaluating soluble TRAIL expression
in the supernatant of naïve and DED-induced LG cocultured with PBMC for indicated time points. All experiments were repeated three
times in triplicate (n = 6/group; **P < 0.01 from the baseline; one-way ANOVA). (E) ELISA analysis evaluating soluble TRAIL expression in
supernatant collected from the cocultures of WT or HIF-1α CKO LG (with or without DED induction) and PBMC at 24 hours. All experiments
were repeated three times in triplicate (n = 6/group; **P < 0.01 from the baseline; one-way ANOVA). (F) Representative flow cytometry data
(left) and cumulative bar chart (right) showing annexin-V+ PBMC cocultured with naïve or DED-induced LGs for indicated time points (n =
6/group; **P < 0.01; one-way ANOVA). (G) Representative flow cytometry data (left) and cumulative bar chart (right) showing annexin-V+
PBMC cocultured with LGs (harvested from naive or DED-induced WT mice) in the presence of control IgG (1.0 μM) and anti-TRAIL antibody
(1.0 μM, and 10 μM) for 24 hours (n = 6/group; **P < 0.01; one-way ANOVA) . (H) Representative flow cytometry data (left) and cumulative
bar chart (right) showing annexin-V+ PBMC cocultured with LGs (harvested from naive or DED-induced HIF-1α CKO mice) in the presence
of control GST (50 ng/mL) or recombinant TRAIL protein (20 ng/mL and 50 ng/mL) for 24 hours (n = 6/group; *P < 0.05, **P < 0.01;
one-way ANOVA, NS: not significant). All the experiments were repeated at least three times.
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FIGURE 4. HIF-1α and TRAIL insufficiency results in enhanced lacrimal gland inflammation and epitheliopathy in DED. (A) Representative
flow cytometry dot plots and histograms showing the infiltration of total CD45+ leukocytes and CD11b+ cells in DED-induced LG from WT
and HIF-1α CKO mice on day 7 of DED induction (n = 6/group). (B) Representative immunohistochemical image of CD11b+ cells in naïve
and DED-induced LGs of WT and HIF-1α CKO mice on indicated days following DED induction (scale bar = 50 μm). (C) Representative
microscopic images showing TUNEL+ apoptotic cells (blue dots) in cross-sections of DED-induced LG from WT and HIF-1α CKO mouse on
indicated days (scale bar = 50 μm). (D) Representative corneal fluorescein staining images (left) and clinical scores of corneal erosions (right)
of WT and HIF-1α CKO mice on indicated days following DED induction. Experiments were repeated at least three times (n = 5/group;
*P < 0.05, **P < 0.01; Student’s t-test).
for cancer.37,38 Our ex vivo coculture experiment reveals
that TRAIL induces apoptosis of leukocytes during desiccat-
ing stress as evidenced by reduced frequency of annexin
V+ apoptotic immune cell in DED-LGs following neutral-
ization of soluble TRAIL. Furthermore, our gain-of-function
approach demonstrates that supplementation of recombi-
nant TRAIL in TRAIL-deficient cultures of HIF-1α CKO
LG significantly promotes immune cell apoptosis following
DED.
TRAIL-induced apoptosis is regulated by TRAIL recep-
tors expressed on target cells.33 Decoy receptors inhibit
activation of the apoptotic signaling cascade by either
sequestering TRAIL from the receptors or by forming
inactive heteromeric DcR1-DR5 complexes.39,40 High
expression of decoy receptors on tumor cells such as acute
myeloid leukemia has been linked with poor prognosis.29,41
Moreover, the modulatory function of the TRAIL-receptor
system has been reported in various autoimmune disor-
ders.42 As demonstrated by our data, acinar cells exhibit
higher expression of mDcR1, whereas infiltrating leuko-
cytes express DR5 during DED induction. This dichotomy
explains the selective apoptosis of CD45+ cells but not
acinar cells in the LG following DED induction, despite the
elevated levels of TRAIL observed. Our study suggests that
acinar cells use the decoy receptor system as a defense
mechanism against TRAIL-induced apoptosis in DED.
In addition to receptor-regulation, the degree of TRAIL
function is determined by the level of TRAIL expressed in
the inflammatory environment. Previous studies have found
TRAIL to be expressed in infiltrating mononuclear cells43
and NK cells44 in autoimmune disorders. Given the previous
findings and the concurrent increase in leukocyte infiltration
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and TRAIL expression during DED, we hypothesized that the
infiltrating leukocytes are the primary source of TRAIL. Inter-
estingly, our study shows that TRAIL in DED is expressed by
acinar cells of the LG, not the infiltrating leukocytes.
Our study illustrates that HIF-1α regulates TRAIL expres-
sion in DED as revealed by a deficiency of TRAIL expres-
sion in HIF-1α conditional knockout mice. Moreover, defi-
ciency of HIF-1α results in elevated immune cell infiltration
following DED induction. HIF-1α has been associated with
immune-mediated disorders, including rheumatoid arthri-
tis45 and tumors.46 The present study further delineates the
immunoregulatory mechanism of HIF-1α in LG inflamma-
tion by demonstrating HIF-1α mediates TRAIL expression in
DED. Furthermore, deficiency of both HIF-1α and TRAIL not
only promote the infiltration of immune cell in LGs but also
results in increased levels of inflammatory cytokines. There-
fore, corneal staining results in DED may reflect the global
effect of altered HIF-1α and TRAIL status on the lacrimal
functional unit because it has an impact on the ocular surface
epithelium.
There are several limitations to this study. First, aside from
HIF-1α activation, an upstream signal for TRAIL induction
was not identified. However, it is still unclear whether the
damage-associated molecular pattern signal or other neural
or hormonal factors may be the main activator of TRAIL
expression in acinar cells. The second limitation is that we
used male B6 mice for this study. The expression levels of
TRAIL might be differentially affected by sex, aging, and
other types of LGs (extra- or intraocular). Additionally, it is
possible that the human TRAIL system is different from that
of mice. Therefore, the present findings regarding TRAIL
expression should only be applied and interpreted to the
murine DED model.
In conclusion, this study highlights the immunoregula-
tory function of TRAIL and its receptor system on the LG in
DED. TRAIL secretion is regulated by acinar cell-derived HIF-
1α and prevents inflammatory damage by promoting apop-
tosis of infiltrating leukocytes. Moreover, differential upregu-
lations of DR5 on leukocytes and DcR on acinar cells induce
selective apoptosis of infiltrating leukocytes in the LG. These
observations could be implicated in designing a potential
TRAIL-based therapeutic strategy to modulate LG inflamma-
tion in DED.
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